Previous 10 | Next 10 |
Testing and revenues will begin in Q4 and continue into Q1-2020 NEW HAVEN, CT / ACCESSWIRE / November 14, 2019 / Specialty diagnostics company Precipio, Inc. ( NASDAQ:PRPO ), announced a substantial biomarker project with a large healthcare company that will generate significant reven...
VistaGen Therapeutics (NASDAQ: VTGN ) -67% on reporting Phase 2 results for AV-101 as a treatment of major depressive disorder. More news on: VistaGen Therapeutics, Inc., Pacific Coast Oil Trust, Ideanomics, Inc., Stocks on the move, Read more ...
Testing yielded substantially better operational and clinical results, including the identification of a Leukemia missed when using a competing media NEW HAVEN, CT / ACCESSWIRE / November 14, 2019 / Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ:PRPO ) announced prelimin...
Precipio, Inc. (PRPO) Q3 2019 Earnings Conference Call November 13, 2019 5:30 PM ET Company Participants Miri Radomski – In-House Counsel Ilan Danieli – Chief Executive Officer Carl Iberger – Chief Financial Officer Conference Call Participants Present...
Precipio (NASDAQ: PRPO ): Q3 GAAP EPS of -$0.31 beats by $0.08 . Revenue of $0.78M (+20.0% Y/Y) misses by $0.32M . Press Release More news on: Precipio, Inc., Earnings news and commentary, Tech stocks news, ,
Conference Call to be held on Wednesday, November 13 th , 2019 at 5:30 PM EST NEW HAVEN, CT / ACCESSWIRE / November 4, 2019 / Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: PRPO ) will be hosting its Third Quarter 2019 corporate update call on Wednesday, November 13 th ...
Yandex (NASDAQ: YNDX ) -8% . More news on: Yandex N.V., OncoSec Medical Incorporated, Precipio, Inc., Stocks on the move, Read more ...
Gainers: Five Prime Therapeutics (NASDAQ: FPRX ) +19% . Ocugen (NASDAQ: OCGN ) +19% . Navios Maritime Holdings (NYSE: NM ) +16% . RISE Education Cayman (NASDAQ: REDU ) +15% . The National Security Group (NASDAQ: NSEC ) +15% . Catabasis Pharmaceuticals (NASDAQ: CATB ) +15% . ele...
Continued Expansion of Academic Expertise Platform NEW HAVEN, CT / ACCESSWIRE / October 9, 2019 / Specialty Diagnostics company Precipio, Inc . ( NASDAQ:PRPO ), announced today a further expansion of its cancer patient access to world-class pathology diagnostics with its partnership fo...
Conference call to be held Thursday October 10 th at 5:00PM EST NEW HAVEN, CT / ACCESSWIRE / October 2, 2019 / Specialty diagnostics company Precipio, Inc. ( NASDAQ:PRPO ), will hold a shareholder update call where CEO Ilan Danieli will discuss the company's commercial progress. The...
News, Short Squeeze, Breakout and More Instantly...
NEW HAVEN, Conn., July 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , announces that for Q2-2024, its unaudited revenues have grown from $3.4M in Q1-2024 to $4.4M in Q2-2024, an increase of 30% from one quarter ago. Patholog...
NEW HAVEN, Conn., June 13, 2024 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO) , today announced that the company’s 2024 Annual Meeting of Shareholders (“Annual Meeting”) was convened and adjourned, without any business being conducted...
NEW HAVEN, Conn., June 12, 2024 (GLOBE NEWSWIRE) -- Management of specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) is requesting that shareholders instruct their brokers to vote their shares immediately today no later than 11pm Eastern Time. In order to e...